Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis

Area of Science:

• Cell Biology
• Regenerative Medicine
• Pathology

Background:

• Direct reprogramming converts differentiated cells into other cell types.
• Fibroblasts, common in reprogramming, also drive fibrosis.
• Reprogramming can deactivate fibrotic pathways.

Purpose of the Study:

• To review advances in direct reprogramming.
• To highlight the anti-fibrosis effects of reprogramming.
• To explore mechanisms linking reprogramming and fibrosis.

Main Methods:

• Review of direct reprogramming literature.
• Analysis of anti-fibrotic effects in cardiac, hepatic, and skin tissues.
• Dissection of molecular mechanisms including TGF-β signaling, mechanical and inflammatory signaling, epigenetic, and metabolic regulation.

Main Results:

• Direct reprogramming demonstrates anti-fibrosis effects across multiple organs.
• Fibrotic molecules significantly influence reprogramming efficiency.
• Innovative reprogramming methods and challenges like cellular heterogeneity and senescence are identified.

Conclusions:

• Direct reprogramming is a promising strategy for tissue regeneration and fibrosis treatment.
• Understanding reprogramming-fibrosis interplay is crucial for therapeutic development.
• Further research into novel methods and in vivo challenges is warranted.